Durvalumab vs Edoxaban

## Durvalumab vs Edoxaban: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Edoxaban**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Edoxaban**: Direct, selective inhibitor of Factor Xa preventing thrombin generation and clot formation.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Edoxaban — 10-14 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Edoxaban — C24H30ClN7O4S.

**Molecular Weight**: Durvalumab — N/A; Edoxaban — 548.0530 g/mol.

**Type**: Durvalumab — Antibody; Edoxaban — Small molecule.